175 related articles for article (PubMed ID: 8225491)
21. 32P-postlabeling assay for carcinogen-DNA adducts and other dna modifications.
Randerath K; Randerath E
J UOEH; 1989 Mar; 11 Suppl():368-86. PubMed ID: 2664950
[TBL] [Abstract][Full Text] [Related]
22. O6-alkyldeoxyguanosine detection by 32P-postlabeling and nucleotide chromatographic analysis.
Wilson VL; Basu AK; Essigmann JM; Smith RA; Harris CC
Cancer Res; 1988 Apr; 48(8):2156-61. PubMed ID: 3349485
[TBL] [Abstract][Full Text] [Related]
23. Detection of adducts arising from human exposure to N-nitroso compounds.
Shuker DE
Cancer Surv; 1989; 8(2):475-87. PubMed ID: 2696591
[TBL] [Abstract][Full Text] [Related]
24. Enzyme-mediated phosphorylation of polycyclic hydrocarbon metabolites: detection of non-adduct compounds in the 32P-postlabelling assay.
Masento MS; Hewer A; Grover PL; Phillips DH
Carcinogenesis; 1989 Aug; 10(8):1557-9. PubMed ID: 2665969
[TBL] [Abstract][Full Text] [Related]
25. Monitoring occupational exposure to carcinogens: detection by 32P-postlabelling of aromatic DNA adducts in white blood cells from iron foundry workers.
Phillips DH; Hemminki K; Alhonen A; Hewer A; Grover PL
Mutat Res; 1988 Mar; 204(3):531-41. PubMed ID: 3347220
[TBL] [Abstract][Full Text] [Related]
26. Some quantitative considerations about DNA adduct enrichment procedures for 32P-postlabelling.
Vaca CE; Löfgren M; Hemminki K
Carcinogenesis; 1992 Dec; 13(12):2463-6. PubMed ID: 1473258
[TBL] [Abstract][Full Text] [Related]
27. DNA adduct formation in human and mouse skin by mixtures of polycyclic aromatic hydrocarbons.
Phillips DH; Schoket B; Hewer A; Grover PL
IARC Sci Publ; 1990; (104):223-9. PubMed ID: 2228120
[TBL] [Abstract][Full Text] [Related]
28. Detection and characterization of carcinogen-DNA adducts in exfoliated urothelial cells from 4-aminobiphenyl-treated dogs by 32P-postlabelling and subsequent thin-layer and high-pressure liquid chromatography.
Talaska G; Dooley KL; Kadlubar FF
Carcinogenesis; 1990 Apr; 11(4):639-46. PubMed ID: 2323002
[TBL] [Abstract][Full Text] [Related]
29. Differences in detection of DNA adducts in the 32P-postlabelling assay after either 1-butanol extraction or nuclease P1 treatment.
Gallagher JE; Jackson MA; George MH; Lewtas J; Robertson IG
Cancer Lett; 1989 Apr; 45(1):7-12. PubMed ID: 2540901
[TBL] [Abstract][Full Text] [Related]
30. Interlaboratory comparison of the 32P-postlabelling assay for aromatic DNA adducts in white blood cells of iron foundry workers.
Savela K; Hemminki K; Hewer A; Phillips DH; Putman KL; Randerath K
Mutat Res; 1989 Dec; 224(4):485-92. PubMed ID: 2586545
[TBL] [Abstract][Full Text] [Related]
31. 32P-adduct assay: comparative recoveries of structurally diverse DNA adducts in the various enhancement procedures.
Gupta RC; Earley K
Carcinogenesis; 1988 Sep; 9(9):1687-93. PubMed ID: 3409474
[TBL] [Abstract][Full Text] [Related]
32. 32P-postlabelling analysis of DNA from human tissues.
Routledge MN; Garner RC; Jenkins D; Cuzick J
Mutat Res; 1992 Jul; 282(3):139-45. PubMed ID: 1378545
[TBL] [Abstract][Full Text] [Related]
33. DNA adduct formation in mice following treatment with used engine oil and identification of some of the major adducts by 32P-postlabelling.
Carmichael PL; Ni Shé M; Hewer A; Jacob J; Grimmer G; Phillips DH
Cancer Lett; 1992 Jun; 64(2):137-44. PubMed ID: 1611597
[TBL] [Abstract][Full Text] [Related]
34. Polycyclic aromatic hydrocarbon-DNA adducts in lung tissue from lung cancer patients.
van Schooten FJ; Hillebrand MJ; van Leeuwen FE; Lutgerink JT; van Zandwijk N; Jansen HM; Kriek E
Carcinogenesis; 1990 Sep; 11(9):1677-81. PubMed ID: 2119262
[TBL] [Abstract][Full Text] [Related]
35. The application of immunoassays and fluorometry to the detection of polycyclic hydrocarbon-macromolecular adducts and anti-adduct antibodies in humans.
Weston A; Rowe M; Poirier M; Trivers G; Vahakangas K; Newman M; Haugen A; Manchester D; Mann D; Harris C
Int Arch Occup Environ Health; 1988; 60(3):157-62. PubMed ID: 3384480
[TBL] [Abstract][Full Text] [Related]
36. Antibodies against 7-methyldeoxyguanosine: its detection in rat peripheral blood lymphocyte DNA and potential applications to molecular epidemiology.
Degan P; Montesano R; Wild CP
Cancer Res; 1988 Sep; 48(18):5065-70. PubMed ID: 3409234
[TBL] [Abstract][Full Text] [Related]
37. Improved reversed-phase high-performance liquid chromatographic separation of 32P-labelled nucleoside 3',5'-bisphosphate adducts of polycyclic aromatic hydrocarbons.
Pfau W; Phillips DH
J Chromatogr; 1991 Sep; 570(1):65-76. PubMed ID: 1797837
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of sensitivity of fluorescence line narrowing spectrometry for detection of carcinogen-DNA adducts.
Jankowiak R; Cooper RS; Zamzow D; Small GJ; Doskocil G; Jeffrey AM
IARC Sci Publ; 1988; (89):372-7. PubMed ID: 3198223
[TBL] [Abstract][Full Text] [Related]
39. 32P-postlabelling detection of aromatic DNA adducts in peripheral blood lymphocytes from aluminium production plant workers.
Schoket B; Phillips DH; Hewer A; Vincze I
Mutat Res; 1991 May; 260(1):89-98. PubMed ID: 2027345
[TBL] [Abstract][Full Text] [Related]
40. Determination of carcinogen-DNA adducts by immunoassay.
Poirier MC; Liou SH; Reed E; Strickland PT; Tockman MS
J UOEH; 1989 Mar; 11 Suppl():353-67. PubMed ID: 2664949
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
